China Everbright lures insurers, eyes fintech and healthcare
The mainland group's Hong Kong investment arm has been busy raising new funds this year and has outlined the types of assets it is targeting.
China Everbright Limited (CEL), the Hong Kong investment arm of mainland financial services group China Everbright, has raised four new funds this year and has identified key areas of investment for both its proprietary portfolio and the private equity strategies it manages for clients. They are elderly care, medical care, semiconductors, consumption upgrading and financial technology.
Sign in to read on!
Registered users get 2 free articles in 30 days.
Subscribers have full unlimited access to AsianInvestor
Not signed up? New users get 2 free articles per month, plus a 7-day unlimited free trial.
¬ Haymarket Media Limited. All rights reserved.